1a:I[76881,["/_next/static/chunks/0qz5kc09grl7v.js","/_next/static/chunks/0t7jsv_ph9pty.js","/_next/static/chunks/185t9cz90ssfr.js","/_next/static/chunks/12nmc~o.gppxb.js","/_next/static/chunks/0ju_3dloy.987.js"],"default"] 1c:I[60790,["/_next/static/chunks/0qz5kc09grl7v.js","/_next/static/chunks/0t7jsv_ph9pty.js","/_next/static/chunks/185t9cz90ssfr.js","/_next/static/chunks/12nmc~o.gppxb.js","/_next/static/chunks/0ju_3dloy.987.js"],"default"] 1d:I[48232,["/_next/static/chunks/0qz5kc09grl7v.js","/_next/static/chunks/0t7jsv_ph9pty.js","/_next/static/chunks/185t9cz90ssfr.js","/_next/static/chunks/12nmc~o.gppxb.js","/_next/static/chunks/0ju_3dloy.987.js"],"default"] 1e:I[2116,["/_next/static/chunks/0qz5kc09grl7v.js","/_next/static/chunks/0t7jsv_ph9pty.js","/_next/static/chunks/185t9cz90ssfr.js","/_next/static/chunks/12nmc~o.gppxb.js","/_next/static/chunks/0ju_3dloy.987.js","/_next/static/chunks/11iefh1iqxrxm.js"],"default"] 1f:I[27201,["/_next/static/chunks/0qz5kc09grl7v.js","/_next/static/chunks/0t7jsv_ph9pty.js","/_next/static/chunks/185t9cz90ssfr.js","/_next/static/chunks/12nmc~o.gppxb.js"],"IconMark"] 1b:T47f,

Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease.

The company offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment clinical blood test targeting CHD events, including heart attacks; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform that offers new epigenetic and genetic insights to clinicians prescribing to help improve chronic care management.

It also provides CardioInnovate360, a research-use-only solution to support the discovery, development and validation of novel biopharmaceuticals for the assessment and management of cardiovascular diseases; and HeartRisk, a SaaS cardiovascular disease risk intelligence platform.

It serves telemedicine providers; provider organizations, such as concierge practices, longevity clinics, and risk-bearing provider organizations; and employer organizations.

Cardio Diagnostics Holdings, Inc. was founded in 2017 and is headquartered in Chicago, Illinois.

No Dividend Data Available